CD274 and neoplasm: In the programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) pathway, the PD-L1 expressed by tumor or tumor-infiltrating immune cells binds to PD-1, inhibiting T-cell receptor signaling and blocking antitumor immune response [2–4].